These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35576520)
1. Beyond the Destounis S AJR Am J Roentgenol; 2022 Sep; 219(3):525. PubMed ID: 35576520 [No Abstract] [Full Text] [Related]
2. Beyond the Lowry KP; Sippo DA AJR Am J Roentgenol; 2021 Jul; 217(1):258. PubMed ID: 33236648 [No Abstract] [Full Text] [Related]
3. Beyond the Dontchos BN; Wang GX AJR Am J Roentgenol; 2022 Jul; 219(1):168. PubMed ID: 35442712 [No Abstract] [Full Text] [Related]
4. Women aged 75 years and older benefit from mammography. Printz C Cancer; 2015 Jan; 121(2):165. PubMed ID: 25581117 [No Abstract] [Full Text] [Related]
10. Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis. Shih YT; Dong W; Xu Y; Etzioni R; Shen Y Ann Intern Med; 2021 May; 174(5):602-612. PubMed ID: 33556275 [TBL] [Abstract][Full Text] [Related]
11. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Schousboe JT; Kerlikowske K; Loh A; Cummings SR Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289 [TBL] [Abstract][Full Text] [Related]
12. Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies". Braillon A Int J Cancer; 2022 Aug; 151(4):649-650. PubMed ID: 35460074 [No Abstract] [Full Text] [Related]
13. Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies". Kregting LM; Sankatsing VDV; Heijnsdijk EAM; de Koning HJ; van Ravesteyn NT Int J Cancer; 2022 Aug; 151(4):651-652. PubMed ID: 35460077 [No Abstract] [Full Text] [Related]
14. Demonstration of Classic Screening Biases, Not Additional Benefit of AnnualĀ Over Biennial Screening. Barratt A; Bell K; Jacklyn G J Am Coll Radiol; 2018 Oct; 15(10):1360. PubMed ID: 30286894 [No Abstract] [Full Text] [Related]
15. Digital Breast Tomosynthesis Screening for Breast Cancer: It Is Cost-effective! Slanetz PJ Radiology; 2020 Oct; 297(1):49-50. PubMed ID: 32772875 [No Abstract] [Full Text] [Related]
16. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program. Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844 [TBL] [Abstract][Full Text] [Related]
17. Total cost-effectiveness of mammography screening strategies. Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235 [TBL] [Abstract][Full Text] [Related]
19. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Mandelblatt JS; Stout N; Trentham-Dietz A Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294 [No Abstract] [Full Text] [Related]
20. The role of screening mammography in the era of modern breast cancer treatment. Miller AB Climacteric; 2018 Jun; 21(3):204-208. PubMed ID: 29338480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]